Neurophth Therapeutics
Neurophth Therapeutics is an ophthalmology Gene Therapy.
2
Funding Rounds
$122.0m
Money raised
Overview
Neurophth Therapeutics is an ophthalmology Gene Therapy.
- Website:
- Headquarters: Wuhan
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Neurophth Therapeutics has raised a total of $122m in funding over 2 rounds.
Key Insights:
- Neurophth Therapeutics Series C round, November 2021: $60m
- Neurophth Therapeutics Series B round, February 2021: $62m
Neurophth Therapeutics Series C round, November 2021
$60m
Neurophth Therapeutics Series B round, February 2021
$62m
Industries
Neurophth Therapeutics is active in the following industries: